Inhibition of hedgehog signalling attenuates UVB-induced skin photoageing

Experimental Dermatology

Volumn 24, Issue 8, 2015, Pages 611-617

  Kim, Wanyeon ^a   Kim, Eungi ^a   Yang, Hee Jung ^a   Kwon, Taewoo ^a   Han, Seoyoung ^a   Lee, Sungmin ^a   Youn, Hyesook ^a   Jung, Youngmi ^a   Kang, Chulhee ^b   Youn, Buhyun ^a  

^a Pusan National University   (South Korea)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

UVB; Evodiamine; Hedgehog; Inflammation; Photoageing

Indexed keywords

CYCLOOXYGENASE 2; EVODIAMINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE P38; SONIC HEDGEHOG PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; 2-(2-AMINO-3-METHOXYPHENYL)-4H-1-BENZOPYRAN-4-ONE; ANILIDE; CYTOKINE; FLAVONOID; MESSENGER RNA; PTGS2 PROTEIN, HUMAN; PYRIDINE DERIVATIVE; QUINAZOLINE DERIVATIVE; TIMP1 PROTEIN, HUMAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VISMODEGIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; KERATINOCYTE; MOUSE; NONHUMAN; PHOTOAGING; PROTEIN EXPRESSION; SENESCENCE; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION; UPREGULATION; ADVERSE EFFECTS; AGING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CUTANEOUS PARAMETERS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; PRECLINICAL STUDY; RADIATION RESPONSE; RAT; SPRAGUE DAWLEY RAT; ULTRAVIOLET RADIATION;

AGING; ANILIDES; ANIMALS; CELL LINE; CYCLOOXYGENASE 2; CYTOKINES; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; GENE EXPRESSION REGULATION; HEDGEHOG PROTEINS; HUMANS; INFLAMMATION; MAP KINASE SIGNALING SYSTEM; MICE; PYRIDINES; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN AGING; TISSUE INHIBITOR OF METALLOPROTEINASE-1; ULTRAVIOLET RAYS;

EID: 84937968459     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12735     Document Type: Article

References (51)

1. Gilchrest B A. J Invest Dermatol 2013: 133: E2-E6.
2. Ichihashi M, Ando H. Exp Dermatol 2014: 23 (Suppl 1): 43-46.
3. Pandel R, Poljsak B, Godic A et al. ISRN Dermatol 2013: 2013: 930164.
4. Yaar M, Gilchrest B A. Br J Dermatol 2007: 157: 874-887.
5. Elia D, Madhala D, Ardon E et al. Biochim Biophys Acta 2007: 1773: 1438-1446.
6. Kim S R, Jung Y R, An H J et al. PLoS ONE 2013: 8: e73877.
7. Briscoe J, Therond P P. Nat Rev Mol Cell Biol 2013: 14: 416-429.
8. Harrison W, Cochrane B, Neill G et al. Oncogene 2014: 33: 2432-2440.
9. Katoh Y, Katoh M. Curr Mol Med 2009: 9: 873-886.
10. Pasca di Maglian M, Hebrok M. Nat Rev Cancer 2003: 3: 903-911.
11. Pantazi E, Gemenetzidis E, Trigiante G et al. Cell Death Dis 2014: 5: e1028.
12. Berman D M, Karhadkar S S, Maitra A et al. Nature 2003: 425: 846-851.
13. Yu H, Jin H, Gong W et al. Molecules 2013: 18: 1826-1843.
14. Liu Y N, Pan S L, Liao C H et al. Shock 2009: 32: 263-269.
15. Jiang J, Hu C. Molecules 2009: 14: 1852-1859.
16. Liao C H, Pan S L, Guh J H et al. Carcinogenesis 2005: 26: 968-975.
17. Nindl I, Dang C, Forschner T et al. Mol Cancer 2006: 5: 30.
18. Athar M, Li C, Tang X et al. Cancer Res 2004: 64: 7545-7552.
19. Brellier F, Marionnet C, Chevallier-Lagente O et al. Cancer Res 2004: 64: 2699-2704.
20. Epstein J H. J Am Acad Dermatol 1983: 9: 487-502.
21. Mann J. Nat Rev Cancer 2002: 2: 143-148.
22. Kim W, Seong K M, Youn B. Exp Mol Med 2011: 43: 323-333.
23. Kim W, Youn H, Kwon T et al. Pharmacol Res 2013: 70: 90-101.
24. Kessaris N, Jamen F, Rubin L L et al. Development 2004: 131: 1289-1298.
25. Tang J Y, Aszterbaum M, Athar M et al. Cancer Prev Res (Phila) 2010: 3: 25-34.
26. Elsawa S F, Almada L L, Ziesmer S C et al. J Biol Chem 2011: 286: 21524-21534.
27. Ghorpade D S, Sinha A Y, Holla S et al. J Biol Chem 2013: 288: 33037-33048.
28. Saqui-Salces M, Coves-Datson E, Veniaminova N A et al. PLoS ONE 2012: 7: e48039.
29. Adachi H, Murakami Y, Tanaka H et al. Exp Dermatol 2014: 23 (Suppl 1): 32-36.
30. Aliouat-Denis C M, Dendouga N, Van den Wyngaert I et al. Mol Cancer Res 2005: 3: 627-634.
31. Mizutani T, Masaki H. Exp Dermatol 2014: 23 (Suppl 1): 23-26.
32. Teperino R, Aberger F, Esterbauer H et al. Semin Cell Dev Biol 2014: 33: 81-92.
33. Varjosalo M, Taipale J. Genes Dev 2008: 22: 2454-2472.
34. Borg M, Brincat S, Camilleri G et al. Climacteric 2013: 16: 514-521.
35. Li W H, Pappas A, Zhang L et al. J Dermatol Sci 2013: 71: 58-66.
36. Lu J T, Zhao W D, He W et al. Acta Pharmacol Sin 2012: 33: 691-700.
37. Atkinson P J, Dellovade T, Albers D et al. J Neurochem 2009: 108: 1539-1549.
38. Weston C R, Wong A, Hall J P et al. Genes Dev 2003: 17: 1271-1280.
39. Pratap A, Panakanti R, Yang N et al. Pharm Res 2010: 27: 2492-2504.
40. Whisenant T C, Ho D T, Benz R W et al. PLoS Comput Biol 2010: 6: e1000908.
41. Zaid M A, Afaq F, Syed D N et al. Photochem Photobiol 2007: 83: 882-888.
42. Kim M S, Oh G H, Kim M J et al. Photochem Photobiol 2013: 89: 911-918.
43. Lin T L, Matsui W. Onco Targets Ther 2012: 5: 47-58.
44. Von Hoff D D, LoRusso P M, Rudin C M et al. N Engl J Med 2009: 361: 1164-1172.
45. Kumari A, Ermilov A N, Allen B L et al. J Neurophysiol 2015: 113: 1034-1040.
46. Dahmane N, Lee J, Robins P et al. Nature 1997: 389: 876-881.
47. Tojo M, Kiyosawa H, Iwatsuki K et al. Br J Dermatol 2003: 148: 892-897.
48. Green J, Leigh I M, Poulsom R et al. Br J Dermatol 1998: 139: 911-915.
49. Kramann R, Schneider R K, DiRocco D P et al. Cell Stem Cell 2015: 16: 51-66.
50. Zhao H, Feng J, Seidel K et al. Cell Stem Cell 2014: 14: 160-173.
51. Heng M C. Int J Dermatol 2011: 50: 1058-1066.